Review



mouse anti sars cov 2 n monoclonal antibody  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    R&D Systems mouse anti sars cov 2 n monoclonal antibody
    Mouse Anti Sars Cov 2 N Monoclonal Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 38 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sars-cov/SARS-CoV-2+Nucleocapsid+MAb+(Clone+1035111)/pmc08942852-317-24-29
    Average 95 stars, based on 38 article reviews
    mouse anti sars cov 2 n monoclonal antibody - by Bioz Stars, 2026-09
    95/100 stars

    Images

    Related Articles

    Virus:

    Article Title: Rational in silico design identifies two mutations that restore UT28K SARS-CoV-2 monoclonal antibody activity against Omicron BA.1.
    Article Snippet: Article Rational in silico design ide ntifies twomutations that restore UT28K SARS-CoV-2 monoclonal antibody activity against Omicron BA.1

    Article Title: Virological characteristics of the SARS-CoV-2 BA.2.86 variant.
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Rabbit anti-SARS-CoV-2 S polyclonal antibody Novus Biologicals Cat# NB100-56578; RRID: AB_838846 Mouse anti-HIV-1 p24monoclonal antibody HIV Reagent Program Cat# 183-H12-5C; RRID: AB_2819250 Mouse anti-a tubulin monoclonal antibody Sigma-Aldrich Cat# T5168; RRID: AB_477579 Goat anti-rabbit secondary HRP conjugate Proteinsimple Cat# 042-206; RRID: AB_2860577 Goat anti-mouse secondary HRP conjugate Psroteinsimple Cat# 042-205; RRID: AB_2860576 Rabbit anti-SARS-CoV-2 S S1/S2 polyclonal antibody Thermo Fisher Scientific Cat# PA5-112048; RRID: AB_2866784 Normal rabbit IgG Southern Biotech Cat# 0111-01; RRID: AB_2732899 APC-conjugated goat anti-rabbit IgG polyclonal antibody Jackson ImmunoResearch Cat# 111-136-144; RRID: AB_2337987 Rabbit anti-SARS-CoV-2 N poly-clonal antibody GeneTex Cat# GTX135570; RRID: AB_2887498 Alexa 488-conjugated anti-rabbit IgG antibody Thermo Fisher Scientific Cat# A-11008; RRID: AB_143165 Mouse anti-SARS-CoV-2 N monoclonal antibody R&D Systems Cat# MAB10474-SP; RRID: N/A Envision FLEX, High pH Agilent Technologies Cat# K8000 RRID: N/A Bacterial and virus strains SARS-CoV-2 BA.2 (strain TY40-385) Kimura et al.22 and Tamura et al.24 N/A SARS-CoV-2 EG.5.1 (strain KU2023071028) Tsujino et al.18 N/A SARS-CoV-2 BA.2.86 (strain TKYnat15020) This study N/A Biological samples Human sera This study N/A Human airway organoids Sano et al.25 N/A Airway-on-a-chips Hashimoto et al.20 N/A Human iPSC-derived lung organoids Hashimoto et al.26 N/A Chemicals, peptides, and recombinant proteins TransIT-LT1 Takara Cat# MIR2300 TransIT-293 transfection reagent Mirus Cat# MIR2704 Recombinant RNase inhibitor Takara Cat# 2313B Fetal bovine serum Sigma-Aldrich Cat# 172012-500ML Penicillin-streptomycin Sigma-Aldrich Cat# P4333-100ML DMEM (high glucose) Sigma-Aldrich Cat# 6429-500ML DMEM (high glucose) Nacalai Tesque Cat# 08458-16 DMEM (low glucose) Wako Cat# 041-29775 EMEM Sigma-Aldrich Cat# M4655-500ML EMEM Wako Cat# 056-08385 EGM-2-MV medium Lonza Cat# CC-3202 DMEM/F12 medium Thermo Fisher Scientific Cat# 11320033 SD-CAA medium Zahradnı́k et al.27 N/A 1/9 medium Zahradnı́k et al.27 N/A Glucose Sigma-Aldrich Cat# G8270 Galactose Sigma-Aldrich Cat# G0750 (Continued on next page) Cell Host & Microbe 32, 170–180.e1–e12, February 14, 2024 e1 .. REAGENT or RESOURCE SOURCE IDENTIFIER Yeast nitrogen base Sigma-Aldrich Cat# Y0626 Casamino acids Sigma-Aldrich Cat# 2240 Sodium phosphate dibasic Sigma-Aldrich Cat# S9763 Sodium phosphate monobasic Sigma-Aldrich Cat# S3139 CF 640R Succinimidyl Ester Biotium Cat# BT92108 PneumaCult ALI medium STEMCELL Technologies Cat# ST-05001 G418 Nacalai Tesque Cat# G8168-10ML N2 FUJIFILM Wako Pure Chemical Cat# 141-08941 B-27 Supplement Minus Vitamin A Thermo Fisher Scientific Cat# 12587001 ascorbic acid STEMCELL Technologies Cat# ST-72132 GlutaMAX Thermo Fisher Scientific Cat# 35050-079 1% monothioglycerol FUJIFILM Wako Pure Chemical Cat# 195-15791 recombinant Activin A R&D Systems Cat# 338-AC-010 dorsomorphin dihydrochloride FUJIFILM Wako Pure Chemical Cat# 047-33763 SB431542 FUJIFILM Wako Pure Chemical Cat# 037-24293 IWP2 Stemolecule Cat# 04-0034 CHIR99021 FUJIFILM Wako Pure Chemical Cat# 032-23104 human FGF10 PeproTech Cat# 100-26 human FGF7 PeproTech Cat# 100-19 human BMP4 PeproTech Cat# 120-05ET human EGF PeproTech Cat# AF-100-15 all-trans retinoic acid Sigma-Aldrich Cat# R2625 dexamethasone Selleck Cat# S1322 8-bromo-cAMP Sigma-Aldrich Cat# B7880 IBMX FUJIFILM Wako Pure Chemical Cat# 099-03411 KpnI New England Biolab Cat# R0142S NotI New England Biolab Cat# R1089S Fibronectin Sigma-Aldrich Cat# F1141 Matrigel growth factor reduced basement membrane Corning Cat# 354230 Triton X-100 Nacalai Tesque Cat# 35501-15 EnduRen live cell substrate Promega Cat# E6481 Soluble human ACE2 (residues 18-618 for binding assay) Yamasoba et al.10 N/A SARS-CoV-2 B.1.1 S RBD Kimura et al.28 and Motozono et al.29 N/A SARS-CoV-2 BA.2 S RBD Kimura et al.30 N/A SARS-CoV-2 XBB.1 S RBD Tamura et al.23 N/A SARS-CoV-2 XBB.1.5 S RBD Uriu et al.14 N/A SARS-CoV-2 BA.2.86 S RBD This study N/A SARS-CoV-2 S RBD derivatives, see Figure 2A This study N/A Bilirubin Sigma-Aldrich Cat# 14370-1G Medetomidine hydrochloride (Domitor ) Nippon Zenyaku Kogyo N/A Midazolam Fujifilm Wako Cat# 135-13791 Butorphanol (Vetorphale ) Meiji Seika Pharma N/A Alphaxaone (Alfaxan ) Jurox N/A Remdesivir Clinisciences Cat# A17170 EIDD-1931 Cell Signalling Technology Cat# 81178S Nirmatrelvir MedChemExpress Cat# HY-138687 (Continued on next page) e2 Cell Host & Microbe 32, 170–180.e1–e12, February 14, 2024

    Recombinant:

    Article Title: Rational in silico design identifies two mutations that restore UT28K SARS-CoV-2 monoclonal antibody activity against Omicron BA.1.
    Article Snippet: Article Rational in silico design ide ntifies twomutations that restore UT28K SARS-CoV-2 monoclonal antibody activity against Omicron BA.1

    Article Title: Virological characteristics of the SARS-CoV-2 BA.2.86 variant.
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Rabbit anti-SARS-CoV-2 S polyclonal antibody Novus Biologicals Cat# NB100-56578; RRID: AB_838846 Mouse anti-HIV-1 p24monoclonal antibody HIV Reagent Program Cat# 183-H12-5C; RRID: AB_2819250 Mouse anti-a tubulin monoclonal antibody Sigma-Aldrich Cat# T5168; RRID: AB_477579 Goat anti-rabbit secondary HRP conjugate Proteinsimple Cat# 042-206; RRID: AB_2860577 Goat anti-mouse secondary HRP conjugate Psroteinsimple Cat# 042-205; RRID: AB_2860576 Rabbit anti-SARS-CoV-2 S S1/S2 polyclonal antibody Thermo Fisher Scientific Cat# PA5-112048; RRID: AB_2866784 Normal rabbit IgG Southern Biotech Cat# 0111-01; RRID: AB_2732899 APC-conjugated goat anti-rabbit IgG polyclonal antibody Jackson ImmunoResearch Cat# 111-136-144; RRID: AB_2337987 Rabbit anti-SARS-CoV-2 N poly-clonal antibody GeneTex Cat# GTX135570; RRID: AB_2887498 Alexa 488-conjugated anti-rabbit IgG antibody Thermo Fisher Scientific Cat# A-11008; RRID: AB_143165 Mouse anti-SARS-CoV-2 N monoclonal antibody R&D Systems Cat# MAB10474-SP; RRID: N/A Envision FLEX, High pH Agilent Technologies Cat# K8000 RRID: N/A Bacterial and virus strains SARS-CoV-2 BA.2 (strain TY40-385) Kimura et al.22 and Tamura et al.24 N/A SARS-CoV-2 EG.5.1 (strain KU2023071028) Tsujino et al.18 N/A SARS-CoV-2 BA.2.86 (strain TKYnat15020) This study N/A Biological samples Human sera This study N/A Human airway organoids Sano et al.25 N/A Airway-on-a-chips Hashimoto et al.20 N/A Human iPSC-derived lung organoids Hashimoto et al.26 N/A Chemicals, peptides, and recombinant proteins TransIT-LT1 Takara Cat# MIR2300 TransIT-293 transfection reagent Mirus Cat# MIR2704 Recombinant RNase inhibitor Takara Cat# 2313B Fetal bovine serum Sigma-Aldrich Cat# 172012-500ML Penicillin-streptomycin Sigma-Aldrich Cat# P4333-100ML DMEM (high glucose) Sigma-Aldrich Cat# 6429-500ML DMEM (high glucose) Nacalai Tesque Cat# 08458-16 DMEM (low glucose) Wako Cat# 041-29775 EMEM Sigma-Aldrich Cat# M4655-500ML EMEM Wako Cat# 056-08385 EGM-2-MV medium Lonza Cat# CC-3202 DMEM/F12 medium Thermo Fisher Scientific Cat# 11320033 SD-CAA medium Zahradnı́k et al.27 N/A 1/9 medium Zahradnı́k et al.27 N/A Glucose Sigma-Aldrich Cat# G8270 Galactose Sigma-Aldrich Cat# G0750 (Continued on next page) Cell Host & Microbe 32, 170–180.e1–e12, February 14, 2024 e1 .. REAGENT or RESOURCE SOURCE IDENTIFIER Yeast nitrogen base Sigma-Aldrich Cat# Y0626 Casamino acids Sigma-Aldrich Cat# 2240 Sodium phosphate dibasic Sigma-Aldrich Cat# S9763 Sodium phosphate monobasic Sigma-Aldrich Cat# S3139 CF 640R Succinimidyl Ester Biotium Cat# BT92108 PneumaCult ALI medium STEMCELL Technologies Cat# ST-05001 G418 Nacalai Tesque Cat# G8168-10ML N2 FUJIFILM Wako Pure Chemical Cat# 141-08941 B-27 Supplement Minus Vitamin A Thermo Fisher Scientific Cat# 12587001 ascorbic acid STEMCELL Technologies Cat# ST-72132 GlutaMAX Thermo Fisher Scientific Cat# 35050-079 1% monothioglycerol FUJIFILM Wako Pure Chemical Cat# 195-15791 recombinant Activin A R&D Systems Cat# 338-AC-010 dorsomorphin dihydrochloride FUJIFILM Wako Pure Chemical Cat# 047-33763 SB431542 FUJIFILM Wako Pure Chemical Cat# 037-24293 IWP2 Stemolecule Cat# 04-0034 CHIR99021 FUJIFILM Wako Pure Chemical Cat# 032-23104 human FGF10 PeproTech Cat# 100-26 human FGF7 PeproTech Cat# 100-19 human BMP4 PeproTech Cat# 120-05ET human EGF PeproTech Cat# AF-100-15 all-trans retinoic acid Sigma-Aldrich Cat# R2625 dexamethasone Selleck Cat# S1322 8-bromo-cAMP Sigma-Aldrich Cat# B7880 IBMX FUJIFILM Wako Pure Chemical Cat# 099-03411 KpnI New England Biolab Cat# R0142S NotI New England Biolab Cat# R1089S Fibronectin Sigma-Aldrich Cat# F1141 Matrigel growth factor reduced basement membrane Corning Cat# 354230 Triton X-100 Nacalai Tesque Cat# 35501-15 EnduRen live cell substrate Promega Cat# E6481 Soluble human ACE2 (residues 18-618 for binding assay) Yamasoba et al.10 N/A SARS-CoV-2 B.1.1 S RBD Kimura et al.28 and Motozono et al.29 N/A SARS-CoV-2 BA.2 S RBD Kimura et al.30 N/A SARS-CoV-2 XBB.1 S RBD Tamura et al.23 N/A SARS-CoV-2 XBB.1.5 S RBD Uriu et al.14 N/A SARS-CoV-2 BA.2.86 S RBD This study N/A SARS-CoV-2 S RBD derivatives, see Figure 2A This study N/A Bilirubin Sigma-Aldrich Cat# 14370-1G Medetomidine hydrochloride (Domitor ) Nippon Zenyaku Kogyo N/A Midazolam Fujifilm Wako Cat# 135-13791 Butorphanol (Vetorphale ) Meiji Seika Pharma N/A Alphaxaone (Alfaxan ) Jurox N/A Remdesivir Clinisciences Cat# A17170 EIDD-1931 Cell Signalling Technology Cat# 81178S Nirmatrelvir MedChemExpress Cat# HY-138687 (Continued on next page) e2 Cell Host & Microbe 32, 170–180.e1–e12, February 14, 2024

    Staining:

    Article Title: Rational in silico design identifies two mutations that restore UT28K SARS-CoV-2 monoclonal antibody activity against Omicron BA.1.
    Article Snippet: Article Rational in silico design ide ntifies twomutations that restore UT28K SARS-CoV-2 monoclonal antibody activity against Omicron BA.1

    Article Title: Effectiveness of VSV vectored SARS-CoV-2 spike when administered through intranasal, intramuscular or a combination of both.
    Article Snippet: .. H&E staining was done on a fully automated Leica ST5010-CV5030 system; SARS-CoV-2 nucleocapsid was detected with mouse anti-SARS-CoV-2 nucleocapsid monoclonal antibody (1:5000, R&D System MAB10474) on the Bond-Max III fully automated staining system (Leica Biosystems, Wetzlar) with a modified F protocol and Bond Polymer Refine Detection. ..

    Membrane:

    Article Title: Rational in silico design identifies two mutations that restore UT28K SARS-CoV-2 monoclonal antibody activity against Omicron BA.1.
    Article Snippet: Article Rational in silico design ide ntifies twomutations that restore UT28K SARS-CoV-2 monoclonal antibody activity against Omicron BA.1

    Transfection:

    Article Title: Rational in silico design identifies two mutations that restore UT28K SARS-CoV-2 monoclonal antibody activity against Omicron BA.1.
    Article Snippet: Article Rational in silico design ide ntifies twomutations that restore UT28K SARS-CoV-2 monoclonal antibody activity against Omicron BA.1

    Article Title: Virological characteristics of the SARS-CoV-2 BA.2.86 variant.
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Rabbit anti-SARS-CoV-2 S polyclonal antibody Novus Biologicals Cat# NB100-56578; RRID: AB_838846 Mouse anti-HIV-1 p24monoclonal antibody HIV Reagent Program Cat# 183-H12-5C; RRID: AB_2819250 Mouse anti-a tubulin monoclonal antibody Sigma-Aldrich Cat# T5168; RRID: AB_477579 Goat anti-rabbit secondary HRP conjugate Proteinsimple Cat# 042-206; RRID: AB_2860577 Goat anti-mouse secondary HRP conjugate Psroteinsimple Cat# 042-205; RRID: AB_2860576 Rabbit anti-SARS-CoV-2 S S1/S2 polyclonal antibody Thermo Fisher Scientific Cat# PA5-112048; RRID: AB_2866784 Normal rabbit IgG Southern Biotech Cat# 0111-01; RRID: AB_2732899 APC-conjugated goat anti-rabbit IgG polyclonal antibody Jackson ImmunoResearch Cat# 111-136-144; RRID: AB_2337987 Rabbit anti-SARS-CoV-2 N poly-clonal antibody GeneTex Cat# GTX135570; RRID: AB_2887498 Alexa 488-conjugated anti-rabbit IgG antibody Thermo Fisher Scientific Cat# A-11008; RRID: AB_143165 Mouse anti-SARS-CoV-2 N monoclonal antibody R&D Systems Cat# MAB10474-SP; RRID: N/A Envision FLEX, High pH Agilent Technologies Cat# K8000 RRID: N/A Bacterial and virus strains SARS-CoV-2 BA.2 (strain TY40-385) Kimura et al.22 and Tamura et al.24 N/A SARS-CoV-2 EG.5.1 (strain KU2023071028) Tsujino et al.18 N/A SARS-CoV-2 BA.2.86 (strain TKYnat15020) This study N/A Biological samples Human sera This study N/A Human airway organoids Sano et al.25 N/A Airway-on-a-chips Hashimoto et al.20 N/A Human iPSC-derived lung organoids Hashimoto et al.26 N/A Chemicals, peptides, and recombinant proteins TransIT-LT1 Takara Cat# MIR2300 TransIT-293 transfection reagent Mirus Cat# MIR2704 Recombinant RNase inhibitor Takara Cat# 2313B Fetal bovine serum Sigma-Aldrich Cat# 172012-500ML Penicillin-streptomycin Sigma-Aldrich Cat# P4333-100ML DMEM (high glucose) Sigma-Aldrich Cat# 6429-500ML DMEM (high glucose) Nacalai Tesque Cat# 08458-16 DMEM (low glucose) Wako Cat# 041-29775 EMEM Sigma-Aldrich Cat# M4655-500ML EMEM Wako Cat# 056-08385 EGM-2-MV medium Lonza Cat# CC-3202 DMEM/F12 medium Thermo Fisher Scientific Cat# 11320033 SD-CAA medium Zahradnı́k et al.27 N/A 1/9 medium Zahradnı́k et al.27 N/A Glucose Sigma-Aldrich Cat# G8270 Galactose Sigma-Aldrich Cat# G0750 (Continued on next page) Cell Host & Microbe 32, 170–180.e1–e12, February 14, 2024 e1 .. REAGENT or RESOURCE SOURCE IDENTIFIER Yeast nitrogen base Sigma-Aldrich Cat# Y0626 Casamino acids Sigma-Aldrich Cat# 2240 Sodium phosphate dibasic Sigma-Aldrich Cat# S9763 Sodium phosphate monobasic Sigma-Aldrich Cat# S3139 CF 640R Succinimidyl Ester Biotium Cat# BT92108 PneumaCult ALI medium STEMCELL Technologies Cat# ST-05001 G418 Nacalai Tesque Cat# G8168-10ML N2 FUJIFILM Wako Pure Chemical Cat# 141-08941 B-27 Supplement Minus Vitamin A Thermo Fisher Scientific Cat# 12587001 ascorbic acid STEMCELL Technologies Cat# ST-72132 GlutaMAX Thermo Fisher Scientific Cat# 35050-079 1% monothioglycerol FUJIFILM Wako Pure Chemical Cat# 195-15791 recombinant Activin A R&D Systems Cat# 338-AC-010 dorsomorphin dihydrochloride FUJIFILM Wako Pure Chemical Cat# 047-33763 SB431542 FUJIFILM Wako Pure Chemical Cat# 037-24293 IWP2 Stemolecule Cat# 04-0034 CHIR99021 FUJIFILM Wako Pure Chemical Cat# 032-23104 human FGF10 PeproTech Cat# 100-26 human FGF7 PeproTech Cat# 100-19 human BMP4 PeproTech Cat# 120-05ET human EGF PeproTech Cat# AF-100-15 all-trans retinoic acid Sigma-Aldrich Cat# R2625 dexamethasone Selleck Cat# S1322 8-bromo-cAMP Sigma-Aldrich Cat# B7880 IBMX FUJIFILM Wako Pure Chemical Cat# 099-03411 KpnI New England Biolab Cat# R0142S NotI New England Biolab Cat# R1089S Fibronectin Sigma-Aldrich Cat# F1141 Matrigel growth factor reduced basement membrane Corning Cat# 354230 Triton X-100 Nacalai Tesque Cat# 35501-15 EnduRen live cell substrate Promega Cat# E6481 Soluble human ACE2 (residues 18-618 for binding assay) Yamasoba et al.10 N/A SARS-CoV-2 B.1.1 S RBD Kimura et al.28 and Motozono et al.29 N/A SARS-CoV-2 BA.2 S RBD Kimura et al.30 N/A SARS-CoV-2 XBB.1 S RBD Tamura et al.23 N/A SARS-CoV-2 XBB.1.5 S RBD Uriu et al.14 N/A SARS-CoV-2 BA.2.86 S RBD This study N/A SARS-CoV-2 S RBD derivatives, see Figure 2A This study N/A Bilirubin Sigma-Aldrich Cat# 14370-1G Medetomidine hydrochloride (Domitor ) Nippon Zenyaku Kogyo N/A Midazolam Fujifilm Wako Cat# 135-13791 Butorphanol (Vetorphale ) Meiji Seika Pharma N/A Alphaxaone (Alfaxan ) Jurox N/A Remdesivir Clinisciences Cat# A17170 EIDD-1931 Cell Signalling Technology Cat# 81178S Nirmatrelvir MedChemExpress Cat# HY-138687 (Continued on next page) e2 Cell Host & Microbe 32, 170–180.e1–e12, February 14, 2024

    Reverse Transcription:

    Article Title: Rational in silico design identifies two mutations that restore UT28K SARS-CoV-2 monoclonal antibody activity against Omicron BA.1.
    Article Snippet: Article Rational in silico design ide ntifies twomutations that restore UT28K SARS-CoV-2 monoclonal antibody activity against Omicron BA.1

    Lysis:

    Article Title: Rational in silico design identifies two mutations that restore UT28K SARS-CoV-2 monoclonal antibody activity against Omicron BA.1.
    Article Snippet: Article Rational in silico design ide ntifies twomutations that restore UT28K SARS-CoV-2 monoclonal antibody activity against Omicron BA.1

    Quantitative RT-PCR:

    Article Title: Rational in silico design identifies two mutations that restore UT28K SARS-CoV-2 monoclonal antibody activity against Omicron BA.1.
    Article Snippet: Article Rational in silico design ide ntifies twomutations that restore UT28K SARS-CoV-2 monoclonal antibody activity against Omicron BA.1

    Activation Assay:

    Article Title: Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant
    Article Snippet: Immunohistochemistry (IHC) (Figs. and ) was performed as previously described using an Autostainer Link 48 (Dako). .. The deparaffinized sections were exposed to EnVision FLEX target retrieval solution high pH (Agilent, Cat# K8004) for 20 minutes at 97 °C for activation, and a mouse anti-SARS-CoV-2 N monoclonal antibody (clone 1035111, R&D Systems, Cat# MAB10474-SP, 1:400) was used as a primary antibody. .. The sections were sensitized using EnVision FLEX for 15 minutes and visualized by peroxidase-based enzymatic reaction with 3,3′-diaminobenzidine tetrahydrochloride (Dako, Cat# DM827) as substrate for 5 minutes.

    Article Title: Virological characteristics of the SARS-CoV-2 BA.2.86 variant.
    Article Snippet: Immunohistochemistry (IHC) (Figures 4C, S3A, and S3B) was performed as previously described10,11,15,19,21–23 using an Autostainer Link 48 (Dako). .. The deparaffinized sections were exposed to EnVision FLEX target retrieval solution high pH (Agilent, Cat# K8004) for 20 minutes at 97 C for activation, and a mouse anti-SARS-CoV-2 N monoclonal antibody (clone 1035111, R&D Systems, Cat# MAB10474-SP, 1:400) was used as a primary antibody. .. The sections were sensitized using EnVision FLEX for 15 minutes and visualized by peroxidase-based enzymatic reaction with 3,30-diaminobenzidine tetrahydrochloride (Dako, Cat# DM827) as substrate for 5 minutes.

    Modification:

    Article Title: Effectiveness of VSV vectored SARS-CoV-2 spike when administered through intranasal, intramuscular or a combination of both.
    Article Snippet: .. H&E staining was done on a fully automated Leica ST5010-CV5030 system; SARS-CoV-2 nucleocapsid was detected with mouse anti-SARS-CoV-2 nucleocapsid monoclonal antibody (1:5000, R&D System MAB10474) on the Bond-Max III fully automated staining system (Leica Biosystems, Wetzlar) with a modified F protocol and Bond Polymer Refine Detection. ..

    Polymer:

    Article Title: Effectiveness of VSV vectored SARS-CoV-2 spike when administered through intranasal, intramuscular or a combination of both.
    Article Snippet: .. H&E staining was done on a fully automated Leica ST5010-CV5030 system; SARS-CoV-2 nucleocapsid was detected with mouse anti-SARS-CoV-2 nucleocapsid monoclonal antibody (1:5000, R&D System MAB10474) on the Bond-Max III fully automated staining system (Leica Biosystems, Wetzlar) with a modified F protocol and Bond Polymer Refine Detection. ..

    Incubation:

    Article Title: Incidence of persistent SARS-CoV-2 gut infection in patients with a history of COVID-19: Insights from endoscopic examination
    Article Snippet: The slices were mounted on positively charged slides and underwent 3,3'-diaminobenzidine (DAB) immunohistochemistry using an automated Dako autostainer (LINK 48). .. After antigen retrieval using EDTA solution for 15 minutes at pH 9, the slides were incubated with an anti-SARS-CoV-2 nucleocapsid monoclonal mouse immunoglobulin-G (IgG) antibody (Bio-techne, USA, #MAB10474–100) at a 1:1000 concentration for 30 minutes. ..

    Concentration Assay:

    Article Title: Incidence of persistent SARS-CoV-2 gut infection in patients with a history of COVID-19: Insights from endoscopic examination
    Article Snippet: The slices were mounted on positively charged slides and underwent 3,3'-diaminobenzidine (DAB) immunohistochemistry using an automated Dako autostainer (LINK 48). .. After antigen retrieval using EDTA solution for 15 minutes at pH 9, the slides were incubated with an anti-SARS-CoV-2 nucleocapsid monoclonal mouse immunoglobulin-G (IgG) antibody (Bio-techne, USA, #MAB10474–100) at a 1:1000 concentration for 30 minutes. ..



    Similar Products

    95
    Sino Biological sars-cov / sars-cov-2 nucleocapsid antibody, mouse mab
    Sars Cov / Sars Cov 2 Nucleocapsid Antibody, Mouse Mab, supplied by Sino Biological, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sars-cov/SARS-CoV+%2F+SARS-CoV-2+Nucleocapsid+Antibody%2C+Mouse+MAb/custom%4040143-mm08%4042476130
    Average 95 stars, based on 1 article reviews
    sars-cov / sars-cov-2 nucleocapsid antibody, mouse mab - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    94
    MedChemExpress sars cov 2 wa 1
    A Schematic <t>of</t> <t>the</t> <t>SARS-CoV-2</t> genome. Targets explicitly labeled and investigated in this study are indicated in black text, while uninvestigated regions are shown in gray. Red markers indicate the binding sites for the vgRNA FISH probes. B Model of a SARS-CoV-2–infected A549-ACE2 cell highlighting the structural evolution of viral replication organelles (ROs) and their previously reported intracellular localizations. Key cellular targets investigated in this study are indicated. C Membrane topology of the uncleaved viral polyproteins pp1a and pp1ab. The schematic illustrates the relative positions of the individual non-structural protein (NSP) domains with respect to the endoplasmic reticulum (ER) membrane following translation. Arrows indicate known proteolytic cleavage sites targeted by nsp3 (orange) and nsp5 (blue).
    Sars Cov 2 Wa 1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sars-cov/SARS-CoV-2+S/pmc13487147-408-13-55
    Average 94 stars, based on 1 article reviews
    sars cov 2 wa 1 - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    86
    Roche roche s elecsys anti sars cov 2 assay
    A Schematic <t>of</t> <t>the</t> <t>SARS-CoV-2</t> genome. Targets explicitly labeled and investigated in this study are indicated in black text, while uninvestigated regions are shown in gray. Red markers indicate the binding sites for the vgRNA FISH probes. B Model of a SARS-CoV-2–infected A549-ACE2 cell highlighting the structural evolution of viral replication organelles (ROs) and their previously reported intracellular localizations. Key cellular targets investigated in this study are indicated. C Membrane topology of the uncleaved viral polyproteins pp1a and pp1ab. The schematic illustrates the relative positions of the individual non-structural protein (NSP) domains with respect to the endoplasmic reticulum (ER) membrane following translation. Arrows indicate known proteolytic cleavage sites targeted by nsp3 (orange) and nsp5 (blue).
    Roche S Elecsys Anti Sars Cov 2 Assay, supplied by Roche, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sars-cov/nct05582512-29-17-21
    Average 86 stars, based on 1 article reviews
    roche s elecsys anti sars cov 2 assay - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    97
    Miltenyi Biotec igm apc pj2 22h3 miltenyi
    A Schematic <t>of</t> <t>the</t> <t>SARS-CoV-2</t> genome. Targets explicitly labeled and investigated in this study are indicated in black text, while uninvestigated regions are shown in gray. Red markers indicate the binding sites for the vgRNA FISH probes. B Model of a SARS-CoV-2–infected A549-ACE2 cell highlighting the structural evolution of viral replication organelles (ROs) and their previously reported intracellular localizations. Key cellular targets investigated in this study are indicated. C Membrane topology of the uncleaved viral polyproteins pp1a and pp1ab. The schematic illustrates the relative positions of the individual non-structural protein (NSP) domains with respect to the endoplasmic reticulum (ER) membrane following translation. Arrows indicate known proteolytic cleavage sites targeted by nsp3 (orange) and nsp5 (blue).
    Igm Apc Pj2 22h3 Miltenyi, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sars-cov/SARS-CoV-2+Spike+B+Cell+Analysis+Kit%2C+anti-human/pm42389809-268-167-170
    Average 97 stars, based on 1 article reviews
    igm apc pj2 22h3 miltenyi - by Bioz Stars, 2026-09
    97/100 stars
      Buy from Supplier

    86
    Acon Biotech Hangzhou Co Ltd sars cov 2 nucleocapsid by immunochromatography
    A Schematic <t>of</t> <t>the</t> <t>SARS-CoV-2</t> genome. Targets explicitly labeled and investigated in this study are indicated in black text, while uninvestigated regions are shown in gray. Red markers indicate the binding sites for the vgRNA FISH probes. B Model of a SARS-CoV-2–infected A549-ACE2 cell highlighting the structural evolution of viral replication organelles (ROs) and their previously reported intracellular localizations. Key cellular targets investigated in this study are indicated. C Membrane topology of the uncleaved viral polyproteins pp1a and pp1ab. The schematic illustrates the relative positions of the individual non-structural protein (NSP) domains with respect to the endoplasmic reticulum (ER) membrane following translation. Arrows indicate known proteolytic cleavage sites targeted by nsp3 (orange) and nsp5 (blue).
    Sars Cov 2 Nucleocapsid By Immunochromatography, supplied by Acon Biotech Hangzhou Co Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sars-cov/pm42035785-87-10-14
    Average 86 stars, based on 1 article reviews
    sars cov 2 nucleocapsid by immunochromatography - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    86
    Biotechnology Information sars cov 2 proteins
    A Schematic <t>of</t> <t>the</t> <t>SARS-CoV-2</t> genome. Targets explicitly labeled and investigated in this study are indicated in black text, while uninvestigated regions are shown in gray. Red markers indicate the binding sites for the vgRNA FISH probes. B Model of a SARS-CoV-2–infected A549-ACE2 cell highlighting the structural evolution of viral replication organelles (ROs) and their previously reported intracellular localizations. Key cellular targets investigated in this study are indicated. C Membrane topology of the uncleaved viral polyproteins pp1a and pp1ab. The schematic illustrates the relative positions of the individual non-structural protein (NSP) domains with respect to the endoplasmic reticulum (ER) membrane following translation. Arrows indicate known proteolytic cleavage sites targeted by nsp3 (orange) and nsp5 (blue).
    Sars Cov 2 Proteins, supplied by Biotechnology Information, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sars-cov/1+2+cov+hu+sars+strain+wuhan/pm42281397-75-13-24
    Average 86 stars, based on 1 article reviews
    sars cov 2 proteins - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    86
    Haibo Inc plant produced sars cov 2 virus
    A Schematic <t>of</t> <t>the</t> <t>SARS-CoV-2</t> genome. Targets explicitly labeled and investigated in this study are indicated in black text, while uninvestigated regions are shown in gray. Red markers indicate the binding sites for the vgRNA FISH probes. B Model of a SARS-CoV-2–infected A549-ACE2 cell highlighting the structural evolution of viral replication organelles (ROs) and their previously reported intracellular localizations. Key cellular targets investigated in this study are indicated. C Membrane topology of the uncleaved viral polyproteins pp1a and pp1ab. The schematic illustrates the relative positions of the individual non-structural protein (NSP) domains with respect to the endoplasmic reticulum (ER) membrane following translation. Arrows indicate known proteolytic cleavage sites targeted by nsp3 (orange) and nsp5 (blue).
    Plant Produced Sars Cov 2 Virus, supplied by Haibo Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sars-cov/2+cov+like+particles+plant+produced+sars+virus/pm42288894-12-5-46
    Average 86 stars, based on 1 article reviews
    plant produced sars cov 2 virus - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    86
    Sanofi sars cov 2 vaccine strain selection
    A Schematic <t>of</t> <t>the</t> <t>SARS-CoV-2</t> genome. Targets explicitly labeled and investigated in this study are indicated in black text, while uninvestigated regions are shown in gray. Red markers indicate the binding sites for the vgRNA FISH probes. B Model of a SARS-CoV-2–infected A549-ACE2 cell highlighting the structural evolution of viral replication organelles (ROs) and their previously reported intracellular localizations. Key cellular targets investigated in this study are indicated. C Membrane topology of the uncleaved viral polyproteins pp1a and pp1ab. The schematic illustrates the relative positions of the individual non-structural protein (NSP) domains with respect to the endoplasmic reticulum (ER) membrane following translation. Arrows indicate known proteolytic cleavage sites targeted by nsp3 (orange) and nsp5 (blue).
    Sars Cov 2 Vaccine Strain Selection, supplied by Sanofi, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sars-cov/2+cov+sars+selection+strain+vaccine/pm42284681-190-24-22
    Average 86 stars, based on 1 article reviews
    sars cov 2 vaccine strain selection - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    86
    Altona Diagnostics realstar sars cov 2 rt pcr kit 1 0
    A Schematic <t>of</t> <t>the</t> <t>SARS-CoV-2</t> genome. Targets explicitly labeled and investigated in this study are indicated in black text, while uninvestigated regions are shown in gray. Red markers indicate the binding sites for the vgRNA FISH probes. B Model of a SARS-CoV-2–infected A549-ACE2 cell highlighting the structural evolution of viral replication organelles (ROs) and their previously reported intracellular localizations. Key cellular targets investigated in this study are indicated. C Membrane topology of the uncleaved viral polyproteins pp1a and pp1ab. The schematic illustrates the relative positions of the individual non-structural protein (NSP) domains with respect to the endoplasmic reticulum (ER) membrane following translation. Arrows indicate known proteolytic cleavage sites targeted by nsp3 (orange) and nsp5 (blue).
    Realstar Sars Cov 2 Rt Pcr Kit 1 0, supplied by Altona Diagnostics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sars-cov/2+cov+kit+pcr+realstar+rt+sars/pm42283351-65-8-16
    Average 86 stars, based on 1 article reviews
    realstar sars cov 2 rt pcr kit 1 0 - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    86
    Abbott Laboratories sars cov 2 igg ii quant assay
    A Schematic <t>of</t> <t>the</t> <t>SARS-CoV-2</t> genome. Targets explicitly labeled and investigated in this study are indicated in black text, while uninvestigated regions are shown in gray. Red markers indicate the binding sites for the vgRNA FISH probes. B Model of a SARS-CoV-2–infected A549-ACE2 cell highlighting the structural evolution of viral replication organelles (ROs) and their previously reported intracellular localizations. Key cellular targets investigated in this study are indicated. C Membrane topology of the uncleaved viral polyproteins pp1a and pp1ab. The schematic illustrates the relative positions of the individual non-structural protein (NSP) domains with respect to the endoplasmic reticulum (ER) membrane following translation. Arrows indicate known proteolytic cleavage sites targeted by nsp3 (orange) and nsp5 (blue).
    Sars Cov 2 Igg Ii Quant Assay, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sars-cov/2+anti+assay+cov+igg+ii+quant+sars/pm42279051-43-10-15
    Average 86 stars, based on 1 article reviews
    sars cov 2 igg ii quant assay - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    Image Search Results


    A Schematic of the SARS-CoV-2 genome. Targets explicitly labeled and investigated in this study are indicated in black text, while uninvestigated regions are shown in gray. Red markers indicate the binding sites for the vgRNA FISH probes. B Model of a SARS-CoV-2–infected A549-ACE2 cell highlighting the structural evolution of viral replication organelles (ROs) and their previously reported intracellular localizations. Key cellular targets investigated in this study are indicated. C Membrane topology of the uncleaved viral polyproteins pp1a and pp1ab. The schematic illustrates the relative positions of the individual non-structural protein (NSP) domains with respect to the endoplasmic reticulum (ER) membrane following translation. Arrows indicate known proteolytic cleavage sites targeted by nsp3 (orange) and nsp5 (blue).

    Journal: Nature Communications

    Article Title: Super-resolution atlas of SARS-CoV-2 infection reveals protease-dependent organelle maturation, dsRNA landscapes, and intracellular structural proteins

    doi: 10.1038/s41467-026-75289-x

    Figure Lengend Snippet: A Schematic of the SARS-CoV-2 genome. Targets explicitly labeled and investigated in this study are indicated in black text, while uninvestigated regions are shown in gray. Red markers indicate the binding sites for the vgRNA FISH probes. B Model of a SARS-CoV-2–infected A549-ACE2 cell highlighting the structural evolution of viral replication organelles (ROs) and their previously reported intracellular localizations. Key cellular targets investigated in this study are indicated. C Membrane topology of the uncleaved viral polyproteins pp1a and pp1ab. The schematic illustrates the relative positions of the individual non-structural protein (NSP) domains with respect to the endoplasmic reticulum (ER) membrane following translation. Arrows indicate known proteolytic cleavage sites targeted by nsp3 (orange) and nsp5 (blue).

    Article Snippet: For nirmatrelvir washout experiments, cells were washed once with PBS and incubated with SARS-CoV-2 WA 1 (USA-WA1/2020) at an MOI of 10 in 50 μL of DMEM containing 2% FBS for 6 h. The viral inoculum was then removed, and cells were cultured in 100 μL of DMEM containing 2% FBS and 288 nM nirmatrelvir (MedChemExpress, HY-138687) for 18 h. A subset of cells was then washed with PBS and fixed by 4% PFA and 0.1% glutaraldehyde in PBS for 1 h. The remaining cells were washed and cultured in fresh DMEM containing 2% FBS for an additional 24 h before being washed and fixed as described above.

    Techniques: Labeling, Binding Assay, Infection, Membrane

    A Representative three-color SR image of a SARS-CoV-2–infected A549-ACE2 cell at an early infection stage, labeled for nsp1 (yellow), nsp4 (magenta) and dsRNA (cyan). Nsp1 localizes diffusely throughout the cytoplasm, while nsp4 encapsulates round dsRNA clusters (double-membrane vesicles, DMVs). B Representative two-color SR image of nsp1 (yellow) and 18S ribosomal RNA (rRNA) (magenta) indicates diffused localization of both targets within the same regions of the cytoplasm. Inset: pair-correlation functions between nsp1 and 18S localizations peak at r = 0 nm, suggesting an association between nsp1 and 18S rRNA. The blue dashed line approximates the position of a nucleolus, characterized by an increased density of 18S rRNA. C Representative SR image of an infected cell at an early infection stage, labeled for nsp2 (magenta), nsp3 (yellow) and dsRNA (cyan). Nsp2 and nsp3 co-encapsulate dsRNA clusters (DMVs) and localize between accumulations of DMVs (putative convoluted membranes, CMs). D In late infection, a significant portion of cellular nsp2 (magenta) localizes to fragmented and dispersed Golgi bodies (labeled with an anti-Giantin antibody, green). Bottom panels (1–3) display magnified views of selected Golgi bodies; yellow arrowheads indicate additional examples of Golgi bodies within the large image. E SR image of a cell in early infection suggests localization of nsp5 (magenta) within DMVs, as indicated by nsp3 (yellow, DMV membrane) and dsRNA (cyan, DMV core). F SR image of a cell at a late infection stage indicates that nsp5 (magenta) localizes to vgRNA-labeled (green) DMVs. Inset: pair-correlation functions between nsp5 and vgRNA localizations in late infection peak at r = 0 nm, indicating a strong correlation between these two targets. In the pair-correlation function plots in ( B ) and ( F ), faint blue lines represent individual cells, faint red lines represent g 12 (r) calculated assuming the complete spatial randomness (CSR), and bold lines represent the mean values across all analyzed cells. Color-framed boxes indicate magnified regions shown in the corresponding panels below. White dashed curves denote the approximate nuclear edge. White arrowheads in ( A ), ( C ), ( E ) indicate selected individual DMVs, whereas green arrowheads point to examples of DMV aggregates associated with nsp3-labeled CMs. Scale bars: 2 µm (large images), 500 nm (magnified images in ( C ), ( D )), and 200 nm (magnified images in ( E ), ( F )).

    Journal: Nature Communications

    Article Title: Super-resolution atlas of SARS-CoV-2 infection reveals protease-dependent organelle maturation, dsRNA landscapes, and intracellular structural proteins

    doi: 10.1038/s41467-026-75289-x

    Figure Lengend Snippet: A Representative three-color SR image of a SARS-CoV-2–infected A549-ACE2 cell at an early infection stage, labeled for nsp1 (yellow), nsp4 (magenta) and dsRNA (cyan). Nsp1 localizes diffusely throughout the cytoplasm, while nsp4 encapsulates round dsRNA clusters (double-membrane vesicles, DMVs). B Representative two-color SR image of nsp1 (yellow) and 18S ribosomal RNA (rRNA) (magenta) indicates diffused localization of both targets within the same regions of the cytoplasm. Inset: pair-correlation functions between nsp1 and 18S localizations peak at r = 0 nm, suggesting an association between nsp1 and 18S rRNA. The blue dashed line approximates the position of a nucleolus, characterized by an increased density of 18S rRNA. C Representative SR image of an infected cell at an early infection stage, labeled for nsp2 (magenta), nsp3 (yellow) and dsRNA (cyan). Nsp2 and nsp3 co-encapsulate dsRNA clusters (DMVs) and localize between accumulations of DMVs (putative convoluted membranes, CMs). D In late infection, a significant portion of cellular nsp2 (magenta) localizes to fragmented and dispersed Golgi bodies (labeled with an anti-Giantin antibody, green). Bottom panels (1–3) display magnified views of selected Golgi bodies; yellow arrowheads indicate additional examples of Golgi bodies within the large image. E SR image of a cell in early infection suggests localization of nsp5 (magenta) within DMVs, as indicated by nsp3 (yellow, DMV membrane) and dsRNA (cyan, DMV core). F SR image of a cell at a late infection stage indicates that nsp5 (magenta) localizes to vgRNA-labeled (green) DMVs. Inset: pair-correlation functions between nsp5 and vgRNA localizations in late infection peak at r = 0 nm, indicating a strong correlation between these two targets. In the pair-correlation function plots in ( B ) and ( F ), faint blue lines represent individual cells, faint red lines represent g 12 (r) calculated assuming the complete spatial randomness (CSR), and bold lines represent the mean values across all analyzed cells. Color-framed boxes indicate magnified regions shown in the corresponding panels below. White dashed curves denote the approximate nuclear edge. White arrowheads in ( A ), ( C ), ( E ) indicate selected individual DMVs, whereas green arrowheads point to examples of DMV aggregates associated with nsp3-labeled CMs. Scale bars: 2 µm (large images), 500 nm (magnified images in ( C ), ( D )), and 200 nm (magnified images in ( E ), ( F )).

    Article Snippet: For nirmatrelvir washout experiments, cells were washed once with PBS and incubated with SARS-CoV-2 WA 1 (USA-WA1/2020) at an MOI of 10 in 50 μL of DMEM containing 2% FBS for 6 h. The viral inoculum was then removed, and cells were cultured in 100 μL of DMEM containing 2% FBS and 288 nM nirmatrelvir (MedChemExpress, HY-138687) for 18 h. A subset of cells was then washed with PBS and fixed by 4% PFA and 0.1% glutaraldehyde in PBS for 1 h. The remaining cells were washed and cultured in fresh DMEM containing 2% FBS for an additional 24 h before being washed and fixed as described above.

    Techniques: Infection, Labeling, Membrane

    A Schematic of a SARS-CoV-2 DMV with dsRNA in the center and nsp4 with nsp3 at the membrane pores. The positions of all remaining components were determined with respect to the known positions of these reference targets. B Representative three-color SR image of the cytoplasm of a typical A549-ACE2 cell at an early infection stage. DMVs (dashed circles) appear as round dsRNA clusters (cyan) surrounded by nsp4 (yellow) and nsp3 (red). A magnified view of a single DMV (white box, top right) reveals the three-layer organization of dsRNA, nsp4, and nsp3. The corresponding radial density distribution functions, g ( r ) (top rightmost plot), and rotationally averaged images (bottom right) display the three-layer structure averaged across n DMVs from 16 different cells. Representative three-color SR images of individual DMVs, corresponding radial density distribution functions, g ( r ), and rotationally averaged images for vgRNA, 18S rRNA, nsp1, nsp2, nsp5 and nsp9 relative to nsp4 and dsRNA. Data were obtained from 10 ( C ), 15 ( D ), 26 ( E ), 13 ( F ), 25 ( G ), and 22 ( H ) individual early-stage infected cells. Where applicable in ( B – H ), the average peak positions, R , of g ( r ), are indicated above the plots as the mean ± 95% CI, obtained via Gaussian fitting of the peak portion of g ( r ) following resampling with replacement (bootstrapping). n represents the total number of analyzed DMVs for each labeling combination. I Mean positions ± 95% CI for all NSPs associated with DMVs, calculated after rescaling the nsp4 positions within individual target groups ( B – H ) to match the global mean position of nsp4. The global position of nsp4 ± 95% CI (yellow error bar) was calculated across 13 groups ( B , F–H ) comprising n = 36,662 DMVs. Detailed data for the remaining NSPs are provided in Supplementary Fig. . J Angular bivariate pair-correlation functions, p ( θ ), of nsp4 with the indicated targets, represented as mean ± 95% CI. All targets peak at θ = 0, except 18S rRNA and nsp1. K Model of a mature, early-stage DMV based on the SR data. Scale bars: 1 µm ( B , overview image), 100 nm ( C – H , K and magnified individual DMVs and rotational averages in B ).

    Journal: Nature Communications

    Article Title: Super-resolution atlas of SARS-CoV-2 infection reveals protease-dependent organelle maturation, dsRNA landscapes, and intracellular structural proteins

    doi: 10.1038/s41467-026-75289-x

    Figure Lengend Snippet: A Schematic of a SARS-CoV-2 DMV with dsRNA in the center and nsp4 with nsp3 at the membrane pores. The positions of all remaining components were determined with respect to the known positions of these reference targets. B Representative three-color SR image of the cytoplasm of a typical A549-ACE2 cell at an early infection stage. DMVs (dashed circles) appear as round dsRNA clusters (cyan) surrounded by nsp4 (yellow) and nsp3 (red). A magnified view of a single DMV (white box, top right) reveals the three-layer organization of dsRNA, nsp4, and nsp3. The corresponding radial density distribution functions, g ( r ) (top rightmost plot), and rotationally averaged images (bottom right) display the three-layer structure averaged across n DMVs from 16 different cells. Representative three-color SR images of individual DMVs, corresponding radial density distribution functions, g ( r ), and rotationally averaged images for vgRNA, 18S rRNA, nsp1, nsp2, nsp5 and nsp9 relative to nsp4 and dsRNA. Data were obtained from 10 ( C ), 15 ( D ), 26 ( E ), 13 ( F ), 25 ( G ), and 22 ( H ) individual early-stage infected cells. Where applicable in ( B – H ), the average peak positions, R , of g ( r ), are indicated above the plots as the mean ± 95% CI, obtained via Gaussian fitting of the peak portion of g ( r ) following resampling with replacement (bootstrapping). n represents the total number of analyzed DMVs for each labeling combination. I Mean positions ± 95% CI for all NSPs associated with DMVs, calculated after rescaling the nsp4 positions within individual target groups ( B – H ) to match the global mean position of nsp4. The global position of nsp4 ± 95% CI (yellow error bar) was calculated across 13 groups ( B , F–H ) comprising n = 36,662 DMVs. Detailed data for the remaining NSPs are provided in Supplementary Fig. . J Angular bivariate pair-correlation functions, p ( θ ), of nsp4 with the indicated targets, represented as mean ± 95% CI. All targets peak at θ = 0, except 18S rRNA and nsp1. K Model of a mature, early-stage DMV based on the SR data. Scale bars: 1 µm ( B , overview image), 100 nm ( C – H , K and magnified individual DMVs and rotational averages in B ).

    Article Snippet: For nirmatrelvir washout experiments, cells were washed once with PBS and incubated with SARS-CoV-2 WA 1 (USA-WA1/2020) at an MOI of 10 in 50 μL of DMEM containing 2% FBS for 6 h. The viral inoculum was then removed, and cells were cultured in 100 μL of DMEM containing 2% FBS and 288 nM nirmatrelvir (MedChemExpress, HY-138687) for 18 h. A subset of cells was then washed with PBS and fixed by 4% PFA and 0.1% glutaraldehyde in PBS for 1 h. The remaining cells were washed and cultured in fresh DMEM containing 2% FBS for an additional 24 h before being washed and fixed as described above.

    Techniques: Membrane, Infection, Labeling

    Representative 3D dSTORM images of DMVs acquired using a double-helix point spread function (DHPSF), colabeled for dsRNA and nsp5 ( A ), nsp8 ( B ), or nsp10 ( C ) in SARS-CoV-2–infected A549-ACE2 cells. Each blue-framed set displays the same DMVs from different viewing angles. Axes are indicated in the corner of each panel (red, X; green, Y; blue, Z). D , E 3D-DHPSF imaging of dsRNA in an infected cell. The magnified view in ( E ) corresponds to the pink box in ( D ). The axial (Z) position of the fluorophores is color-coded according to the provided scale, where 0 µm represents the coverslip. F 2D dSTORM images of dsRNA colabeled with nsp4 reveal thin dsRNA connectors between larger dsRNA structures. These images correspond to the yellow boxes in the whole-cell image shown in Supplementary Fig. . G Examples of a cell in an early infection stage that contains large, approximately round dsRNA granules decorated with nsp9 puncta but lacking an nsp4 shell. The magnified panels on the right correspond to the green box in the large image. Green arrowheads highlight additional examples of dsRNA connectors, and white arrowheads indicate selected dsRNA granules lacking nsp4. Examples of large dsRNA granules largely lacking nsp4 but decorated with nsp5 ( H ), nsp13 ( I ), and nsp8 ( J ). White dashed curves denote the approximate nuclear edge. Scale bars: 5 µm (whole-cell images in D , G ), 500 nm ( H – J , and magnified panels in G ), and 200 nm ( A – C , E , F ).

    Journal: Nature Communications

    Article Title: Super-resolution atlas of SARS-CoV-2 infection reveals protease-dependent organelle maturation, dsRNA landscapes, and intracellular structural proteins

    doi: 10.1038/s41467-026-75289-x

    Figure Lengend Snippet: Representative 3D dSTORM images of DMVs acquired using a double-helix point spread function (DHPSF), colabeled for dsRNA and nsp5 ( A ), nsp8 ( B ), or nsp10 ( C ) in SARS-CoV-2–infected A549-ACE2 cells. Each blue-framed set displays the same DMVs from different viewing angles. Axes are indicated in the corner of each panel (red, X; green, Y; blue, Z). D , E 3D-DHPSF imaging of dsRNA in an infected cell. The magnified view in ( E ) corresponds to the pink box in ( D ). The axial (Z) position of the fluorophores is color-coded according to the provided scale, where 0 µm represents the coverslip. F 2D dSTORM images of dsRNA colabeled with nsp4 reveal thin dsRNA connectors between larger dsRNA structures. These images correspond to the yellow boxes in the whole-cell image shown in Supplementary Fig. . G Examples of a cell in an early infection stage that contains large, approximately round dsRNA granules decorated with nsp9 puncta but lacking an nsp4 shell. The magnified panels on the right correspond to the green box in the large image. Green arrowheads highlight additional examples of dsRNA connectors, and white arrowheads indicate selected dsRNA granules lacking nsp4. Examples of large dsRNA granules largely lacking nsp4 but decorated with nsp5 ( H ), nsp13 ( I ), and nsp8 ( J ). White dashed curves denote the approximate nuclear edge. Scale bars: 5 µm (whole-cell images in D , G ), 500 nm ( H – J , and magnified panels in G ), and 200 nm ( A – C , E , F ).

    Article Snippet: For nirmatrelvir washout experiments, cells were washed once with PBS and incubated with SARS-CoV-2 WA 1 (USA-WA1/2020) at an MOI of 10 in 50 μL of DMEM containing 2% FBS for 6 h. The viral inoculum was then removed, and cells were cultured in 100 μL of DMEM containing 2% FBS and 288 nM nirmatrelvir (MedChemExpress, HY-138687) for 18 h. A subset of cells was then washed with PBS and fixed by 4% PFA and 0.1% glutaraldehyde in PBS for 1 h. The remaining cells were washed and cultured in fresh DMEM containing 2% FBS for an additional 24 h before being washed and fixed as described above.

    Techniques: Infection, Imaging

    A Representative SR image of the M protein reveals distinct morphological structures. Magnified panels on the right correspond to the blue, green, and red boxes in the main image. B Representative SR image of the M protein shows virions arrayed on the cell membrane. Insets (yellow boxes) display magnified individual virions. C Representative two-color SR image of M protein (magenta) and the Golgi marker Giantin (green) indicates that M protein localizes within the Golgi apparatus. Bottom panels show magnified views of the region enclosed by the yellow box. D Representative two-color SR image of M protein (magenta) and the lysosomal marker LAMP1 (green) details the distribution of M protein inside and outside lysosomes. Panels on the right show magnified views of the regions enclosed by the corresponding colored boxes. E Representative two-color SR images demonstrate that M protein (magenta) codistributes with S1 protein (green) in both hollow (top) and solid (bottom) clusters. F Histogram of the equivalent radius of solid (blue, n = 276 clusters) and hollow (red, n = 180 clusters) M protein structures reveals two distinct size populations. Data were obtained from 22 cells and 8 independent experiments. G Representative two-color SR image of vgRNA (magenta) and N protein (green) at 24 hpi demonstrates colocalization exclusively in the cytoplasm outside ROs. Panels on the right show magnified views of the regions enclosed by the yellow and blue boxes. H Bivariate pair-correlation functions, g 12 ( r ), calculated between vgRNA and N protein localizations in the cytoplasm outside ROs indicate their close spatial association. I Representative two-color SR image of vgRNA (magenta) and S2 protein (green) shows a lack of colocalization both within and outside ROs. Panels on the right show magnified views of the regions enclosed by the corresponding colored boxes. J Bivariate pair-correlation functions, g 12 ( r ), calculated between vgRNA and S2 protein localizations in the cytoplasm outside ROs indicate a nanoscale spatial anti-correlation between them. White dashed lines in A , C , D , G , and I denote the approximate edge of the cell nucleus (large dark region). Color bars in A , B , D , E indicate the number of single-molecule localizations per SR pixel (20 × 20 nm 2 , except for B , 16 × 16 nm 2 ). Scale bars: 10 µm (large image in A ), 5 µm (large images in B – D , G , I ), 1 µm (magnified images in A, C), and 500 nm ( E and magnified images in D , G , I ). Images and data in A – F were obtained from SARS-CoV-2–infected A549-ACE2 cells, whereas those in G – J were obtained from infected Vero E6 cells. All cells were fixed at 24 hpi.

    Journal: Nature Communications

    Article Title: Super-resolution atlas of SARS-CoV-2 infection reveals protease-dependent organelle maturation, dsRNA landscapes, and intracellular structural proteins

    doi: 10.1038/s41467-026-75289-x

    Figure Lengend Snippet: A Representative SR image of the M protein reveals distinct morphological structures. Magnified panels on the right correspond to the blue, green, and red boxes in the main image. B Representative SR image of the M protein shows virions arrayed on the cell membrane. Insets (yellow boxes) display magnified individual virions. C Representative two-color SR image of M protein (magenta) and the Golgi marker Giantin (green) indicates that M protein localizes within the Golgi apparatus. Bottom panels show magnified views of the region enclosed by the yellow box. D Representative two-color SR image of M protein (magenta) and the lysosomal marker LAMP1 (green) details the distribution of M protein inside and outside lysosomes. Panels on the right show magnified views of the regions enclosed by the corresponding colored boxes. E Representative two-color SR images demonstrate that M protein (magenta) codistributes with S1 protein (green) in both hollow (top) and solid (bottom) clusters. F Histogram of the equivalent radius of solid (blue, n = 276 clusters) and hollow (red, n = 180 clusters) M protein structures reveals two distinct size populations. Data were obtained from 22 cells and 8 independent experiments. G Representative two-color SR image of vgRNA (magenta) and N protein (green) at 24 hpi demonstrates colocalization exclusively in the cytoplasm outside ROs. Panels on the right show magnified views of the regions enclosed by the yellow and blue boxes. H Bivariate pair-correlation functions, g 12 ( r ), calculated between vgRNA and N protein localizations in the cytoplasm outside ROs indicate their close spatial association. I Representative two-color SR image of vgRNA (magenta) and S2 protein (green) shows a lack of colocalization both within and outside ROs. Panels on the right show magnified views of the regions enclosed by the corresponding colored boxes. J Bivariate pair-correlation functions, g 12 ( r ), calculated between vgRNA and S2 protein localizations in the cytoplasm outside ROs indicate a nanoscale spatial anti-correlation between them. White dashed lines in A , C , D , G , and I denote the approximate edge of the cell nucleus (large dark region). Color bars in A , B , D , E indicate the number of single-molecule localizations per SR pixel (20 × 20 nm 2 , except for B , 16 × 16 nm 2 ). Scale bars: 10 µm (large image in A ), 5 µm (large images in B – D , G , I ), 1 µm (magnified images in A, C), and 500 nm ( E and magnified images in D , G , I ). Images and data in A – F were obtained from SARS-CoV-2–infected A549-ACE2 cells, whereas those in G – J were obtained from infected Vero E6 cells. All cells were fixed at 24 hpi.

    Article Snippet: For nirmatrelvir washout experiments, cells were washed once with PBS and incubated with SARS-CoV-2 WA 1 (USA-WA1/2020) at an MOI of 10 in 50 μL of DMEM containing 2% FBS for 6 h. The viral inoculum was then removed, and cells were cultured in 100 μL of DMEM containing 2% FBS and 288 nM nirmatrelvir (MedChemExpress, HY-138687) for 18 h. A subset of cells was then washed with PBS and fixed by 4% PFA and 0.1% glutaraldehyde in PBS for 1 h. The remaining cells were washed and cultured in fresh DMEM containing 2% FBS for an additional 24 h before being washed and fixed as described above.

    Techniques: Membrane, Marker, Infection

    A Representative SR image of an infected cell (MOI = 2) treated with 144 nM nirmatrelvir from 0 to 24 hpi and fixed at 24 hpi. Two regions with large multilayered bodies (MLBs) are magnified in the central panels. Density profiles (right, panels 1 and 2) show the localization density of nsp4 and nsp5 calculated perpendicular to the corresponding numbered white curves, in the direction indicated by the arrows (localization density orthogonal to the arrows was averaged). Both nsp4 and nsp5 localize in layered structures with a periodicity of ∼75 nm. SR images of infected cells (MOI = 10) treated with 288 nM nirmatrelvir from 6 to 24 hpi and fixed at 24 hpi. Nsp10 ( B ), nsp16 ( C ) and nsp3 ( D ) localize to the same multilayered structures as nsp5. E Magnified view of the region in ( D ) demonstrates the localization of nsp3 on both sides of nsp5-labeled layers. The averaged density profiles of nsp3 and nsp5 (right), calculated perpendicular to the numbered white curves in the direction of the arrows, reveal a double structure of nsp3 layers centered on single nsp5 layers. F , G Additional examples of MLBs from different cells in the same sample group, exhibiting this double nsp3 layer structure. H Confocal images of infected cells (MOI = 10) treated with 288 nM nirmatrelvir from 6 to 24 hpi and fixed at either 24 hpi (left) or 48 hpi (right), utilizing lysosome-associated membrane protein 1 (LAMP1, green) as a general cellular marker. In the left panel, only 6 cells in the bottom right corner display a weak punctate nsp5 signal (magenta) typical for an early infection phenotype, whereas the remaining cells show only LAMP1 signal and no detectable nsp5. In the right panel, nearly all cells exhibit a strong perinuclear nsp5 signal consistent with late-stage infection. I , J SR images of infected cells (MOI = 10) treated with 288 nM nirmatrelvir from 6 to 24 hpi and fixed at 48 hpi. A typical cell under these conditions displays a late-infection phenotype with highly dense perinuclear NSP and dsRNA localizations ( I ), whereas another typical cell shows prominent cytoplasmic MLBs ( J ). Among 32 infected cells imaged in SR at 48 hpi, 16 (50%) contained MLBs. In contrast, among 41 similarly treated infected cells fixed at 24 hpi (examples shown in B–G), 29 (∼71%) contained MLBs. White dashed curves denote the approximate nuclear edge. Scale bars: 50 µm ( H ), 5 µm (large images in A ; D , I , J ), 1 µm (middle panels in A ; B , C ), and 500 nm ( E – G ). All images and data were obtained from SARS-CoV-2–infected A549-ACE2 cells.

    Journal: Nature Communications

    Article Title: Super-resolution atlas of SARS-CoV-2 infection reveals protease-dependent organelle maturation, dsRNA landscapes, and intracellular structural proteins

    doi: 10.1038/s41467-026-75289-x

    Figure Lengend Snippet: A Representative SR image of an infected cell (MOI = 2) treated with 144 nM nirmatrelvir from 0 to 24 hpi and fixed at 24 hpi. Two regions with large multilayered bodies (MLBs) are magnified in the central panels. Density profiles (right, panels 1 and 2) show the localization density of nsp4 and nsp5 calculated perpendicular to the corresponding numbered white curves, in the direction indicated by the arrows (localization density orthogonal to the arrows was averaged). Both nsp4 and nsp5 localize in layered structures with a periodicity of ∼75 nm. SR images of infected cells (MOI = 10) treated with 288 nM nirmatrelvir from 6 to 24 hpi and fixed at 24 hpi. Nsp10 ( B ), nsp16 ( C ) and nsp3 ( D ) localize to the same multilayered structures as nsp5. E Magnified view of the region in ( D ) demonstrates the localization of nsp3 on both sides of nsp5-labeled layers. The averaged density profiles of nsp3 and nsp5 (right), calculated perpendicular to the numbered white curves in the direction of the arrows, reveal a double structure of nsp3 layers centered on single nsp5 layers. F , G Additional examples of MLBs from different cells in the same sample group, exhibiting this double nsp3 layer structure. H Confocal images of infected cells (MOI = 10) treated with 288 nM nirmatrelvir from 6 to 24 hpi and fixed at either 24 hpi (left) or 48 hpi (right), utilizing lysosome-associated membrane protein 1 (LAMP1, green) as a general cellular marker. In the left panel, only 6 cells in the bottom right corner display a weak punctate nsp5 signal (magenta) typical for an early infection phenotype, whereas the remaining cells show only LAMP1 signal and no detectable nsp5. In the right panel, nearly all cells exhibit a strong perinuclear nsp5 signal consistent with late-stage infection. I , J SR images of infected cells (MOI = 10) treated with 288 nM nirmatrelvir from 6 to 24 hpi and fixed at 48 hpi. A typical cell under these conditions displays a late-infection phenotype with highly dense perinuclear NSP and dsRNA localizations ( I ), whereas another typical cell shows prominent cytoplasmic MLBs ( J ). Among 32 infected cells imaged in SR at 48 hpi, 16 (50%) contained MLBs. In contrast, among 41 similarly treated infected cells fixed at 24 hpi (examples shown in B–G), 29 (∼71%) contained MLBs. White dashed curves denote the approximate nuclear edge. Scale bars: 50 µm ( H ), 5 µm (large images in A ; D , I , J ), 1 µm (middle panels in A ; B , C ), and 500 nm ( E – G ). All images and data were obtained from SARS-CoV-2–infected A549-ACE2 cells.

    Article Snippet: For nirmatrelvir washout experiments, cells were washed once with PBS and incubated with SARS-CoV-2 WA 1 (USA-WA1/2020) at an MOI of 10 in 50 μL of DMEM containing 2% FBS for 6 h. The viral inoculum was then removed, and cells were cultured in 100 μL of DMEM containing 2% FBS and 288 nM nirmatrelvir (MedChemExpress, HY-138687) for 18 h. A subset of cells was then washed with PBS and fixed by 4% PFA and 0.1% glutaraldehyde in PBS for 1 h. The remaining cells were washed and cultured in fresh DMEM containing 2% FBS for an additional 24 h before being washed and fixed as described above.

    Techniques: Infection, Labeling, Membrane, Marker